Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Q2 results will drive short squeeze
View:
Post by dusoft24x7 on Aug 10, 2016 6:44pm

Q2 results will drive short squeeze

Very strong Q2 results expected.   Bad time starts now for shorts, ready to be blown away.
Comment by LatticelnExile on Aug 10, 2016 6:52pm
This post has been removed in accordance with Community Policy
Comment by TraderBen on Aug 10, 2016 7:25pm
I plan to sell at 3:55 tomorrow if the share price goes sidesways again tomorrow and rebuy after I see the results and if good I will buy and trade.  I may miss out on a bit but it worked out nicely with Valeant and not worth the risk IMO if it goes down hard.  Shorts are not being squeezed this week and short interest is astoundingly high and doesn't seem to be covering. I am just ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities